[11].Khera AV, et al. Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin). Circulation. 2014 Feb 11;129(6):635-42. [12].Tsimikas...
3. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L,Chapman MJ, De Backer GG, Delgado V, Ference BA, et al; ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemi...
ASCVD Risk Refinement With NT-proBNP for Statin Allocation Among Low- and Intermediate-Risk Individualsdoi:10.1161/CIRCULATIONAHA.124.071071atherosclerotic cardiovascular diseaseepidemiologyN-terminal pro-B-type natriuretic peptidepopulation-basedprimary prevention...
The 2019 ACC/AHA guidelines recommend either a high-intensity or moderate-intensity statin regimen in patients who have an elevated ASCVD risk (≥ 5-7.5%) for primary prevention of cardiovascular disease. The recommended doses for each of these regimens are shown below: ...
[10]Villani R, Navarese EP, Cavallone F, Kubica J, Bellanti F, Facciorusso A, Vendemiale G, Serviddio G. Risk of Statin-Induced Hypertransaminasemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Mayo C...
Risk prediction for cardiovascular disease continues to be an active area of research. In 2013, the American Heart Association (AHA) and the American College of Cardiology (ACC) released a new set of guidelines for statin therapy based on risk estimates from the atherosclerotic cardiovascular disease...
Implications of the US Cholesterol Guidelines on Eligibility for Statin Therapy in the Community: Comparison of Observed and Predicted Risks in the Framing... Background Concerns have been raised that the 2013 atherosclerotic cardiovascular disease (ASCVD) risk estimator overpredicts risk in contemporary...
1. Noriyuki Wakana, Hideo Tsubata, Kan Zen.A case report:near-infrared spectroscopy ultrasonography can detect the plaque stabilization of non-culprit lesion in ACS patients by the combination therapy of PCSK9 inhibitor and statin.JACC.2019;73:(9) Supplement 1. ...
RegisterLog in Sign up with one click: Facebook Twitter Google Share on Facebook ASCVD Acronyms Arteriosclerotic cardiovascular disease. SeeAtherosclerosis, Artherosclerotic heart disease. McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc. ...
1. Özcan C, et al.Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study Eur Heart J Cardiovasc Pharmacother. 2018 Jan 1;4(1):25-35.